0001096906-24-001026.txt : 20240506 0001096906-24-001026.hdr.sgml : 20240506 20240506150538 ACCESSION NUMBER: 0001096906-24-001026 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240503 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240506 DATE AS OF CHANGE: 20240506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 24917140 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utmd-20240503.htm UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING UTAH MEDICAL PRODUCTS, INC. - Form 8-K SEC filing
0000706698 false false false false false false 0000706698 2024-05-03 2024-05-03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

 

 

Date of Report (date of earliest event reported): May 3, 2024

 

 

 Commission File No. 001-12575

 

 

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

 

UTAH

 

 

87-0342734

(State or other jurisdiction of

 

 

(IRS Employer

incorporation or organization)

 

 

Identification No.)

 

 

7043 South 300 West

Midvale, Utah  84047

Address of principal executive offices

 

 

Registrant's telephone number: (801) 566-1200

 

ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

 

 

On May 3, 2024 at the Company’s annual meeting of stockholders, stockholders approved, did not approve or indicated their preference on the following matters submitted to them for consideration:

 

 

Elected Kevin L. Cornwell as a director of the Company: 

For  1,436,389Withheld1,304,680Broker Non Votes 324,644 

 

Elected Paul O. Richins as a director of the Company: 

For907,483Withheld1,833,586Broker Non Votes 324,644 

 

Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2024: 

For3,012,801Against49,443Abstentions 3,469 

 

Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: 

For2,662,106Against  72,899Abstentions 6,064     Broker Non Votes 324,644 

 

 

Per Company policy, Mr. Richins tendered his resignation, which was conditioned upon acceptance by the Board of Directors. The Board of Directors voted not to accept his resignation.  Per Utah law, Mr. Richins was elected to serve a three-year term and until his successor is elected and qualified.

 

The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials.  Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

 

 

UTAH MEDICAL PRODUCTS, INC. 

REGISTRANT 

 

 

Date:        5/03/2024                   By:     /s/ Kevin L. Cornwell                          

    Kevin L. Cornwell 

    Chairman & CEO 

 EX-101.DEF 2 utmd-20240503_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 3 utmd-20240503_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Entity Address, Postal Zip Code Ex Transition Period Voluntary filer Interactive Data Current SEC Form Pre-commencement Tender Offer Filer Category Amendment Description City Area Code Emerging Growth Company Public Float Trading Symbol Fiscal Year End Registrant Name Entity Incorporation, State or Country Code Pre-commencement Issuer Tender Offer Period End date Number of common stock shares outstanding Amendment Flag Local Phone Number Shell Company Entity Address, State or Province Current with reporting Tax Identification Number (TIN) Entity Address, City or Town Written Communications Small Business Registrant CIK Securities Act File Number Soliciting Material Trading Exchange Entity Address, Address Line One Well-known Seasoned Issuer Details EX-101.PRE 4 utmd-20240503_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.SCH 5 utmd-20240503.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information
May 03, 2024
Details  
Registrant CIK 0000706698
Registrant Name UTAH MEDICAL PRODUCTS, INC.
SEC Form 8-K
Period End date May 03, 2024
Tax Identification Number (TIN) 87-0342734
Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Securities Act File Number 001-12575
Entity Incorporation, State or Country Code UT
Entity Address, Address Line One 7043 South 300 West
Entity Address, City or Town Midvale
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84047
City Area Code 801
Local Phone Number 566-1200
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 19 1 false 0 0 false 0 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityEmergingGrowthCompany - utmd-20240503.htm 17 utmd-20240503.htm utmd-20240503.xsd utmd-20240503_def.xml utmd-20240503_lab.xml utmd-20240503_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "utmd-20240503.htm": { "nsprefix": "fil", "nsuri": "http://utahmed.com/20240503", "dts": { "inline": { "local": [ "utmd-20240503.htm" ] }, "schema": { "local": [ "utmd-20240503.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "utmd-20240503_def.xml" ] }, "labelLink": { "local": [ "utmd-20240503_lab.xml" ] }, "presentationLink": { "local": [ "utmd-20240503_pre.xml" ] } }, "keyStandard": 19, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2023": 7 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 34, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 19 }, "report": { "R1": { "role": "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation", "longName": "000010 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "D240503", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "utmd-20240503.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "D240503", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "utmd-20240503.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Fiscal Year End", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Period End date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "SEC Form", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant CIK", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Number of common stock shares outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current with reporting", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r8" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r0" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r5" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r0" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Tax Identification Number (TIN)", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Voluntary filer", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r6" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Exchange", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_TextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TextBlockAbstract", "lang": { "en-us": { "role": { "label": "Details" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://utahmed.com/20240503/role/idr_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r7" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001096906-24-001026-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001096906-24-001026-xbrl.zip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utmd-20240503_htm.xml IDEA: XBRL DOCUMENT 0000706698 2024-05-03 2024-05-03 0000706698 false false false false false false 8-K 2024-05-03 001-12575 UTAH MEDICAL PRODUCTS, INC. UT 87-0342734 7043 South 300 West Midvale UT 84047 801 566-1200